耳鼻咽喉科臨床
Online ISSN : 1884-4545
Print ISSN : 0032-6313
ISSN-L : 0032-6313
高度難聴に対する内耳への薬物局所投与による臨床試験
伊藤 壽一
著者情報
ジャーナル フリー

2008 年 101 巻 1 号 p. 1-4

詳細
抄録
There is no effective treatment for sensorinenral hearing disturbance. Inner ear sensory cells have been considered very fragile and functional recovery after damage is very difficult, making sensorinenral hearing loss very difficult to treat. Recently several drugs and chemicals have been reported to protect or promote recovery of inner ear function. However, applying those drugs to the inner ear is difficult because of specific anatomical and physiological factors. However, new technology using a drug delivery system (DDS) has introduced new possibilities. Especially, application of nerve growth factor in a biodegradable hydrogel is thought to be effective for protection and recovery of the inner ear function. We have reported the effectiveness of several drugs, especially nerve growth factors to prevent inner ear hair cell damage due to noise exposure or ototoxic chemicals in animals. We have begun a clinical trial using Insulin-like growth factor 1 (IGF-1) for the treatment of sudden deafness.
著者関連情報
© 耳鼻咽喉科臨学会
次の記事
feedback
Top